Ovarian luteinizing hormone priming preceding follicle-stimulating hormone stimulation: clinical and endocrine effects in women with long-term hypogonadotropic hypogonadism
- PMID: 19366842
- DOI: 10.1210/jc.2009-0262
Ovarian luteinizing hormone priming preceding follicle-stimulating hormone stimulation: clinical and endocrine effects in women with long-term hypogonadotropic hypogonadism
Abstract
Context: Patients with hypogonadotropic hypogonadism (HH), who may be totally LH deficient, remain the primary clinical model for investigating the physiology of gonadotropin actions on ovarian steroidogenesis and follicular development.
Objectives: Our objective was to investigate the effects of LH pretreatment on subsequent ovarian stimulation with FSH in longstanding HH women.
Design and setting: A prospective, self-controlled study was conducted at a university tertiary-care center.
Patients and interventions: Eight HH women (six idiopathic, two surgical) underwent ovarian stimulation with recombinant human (rh)FSH preceded or not by rhLH administration in two separate cycles. In one additional patient with idiopathic HH, pretreatment was conducted with recombinant human chorionic gonadotropin (rhCG) instead of rhLH.
Main outcome measures: Follicular development and serum hormone concentrations throughout LH-FSH and FSH treatment cycles were assessed.
Results: Pretreatment with rhLH significantly decreased the mean threshold (daily effective) FSH dose and tended to lower the total amount of FSH required to induce follicular maturation in association with appropriate serum estradiol levels and endometrial thickness. Unexpectedly, in HH women retaining functional pituitary tissue, pretreatment with rhLH evoked a consistent elevation of serum LH levels during FSH administration, an effect that was also induced, even at higher magnitude, by pretreatment with rhCG.
Conclusions: In addition to changes in FSH requirements for follicular maturation, pretreatment with rhLH/rhCG evoked unambiguous elevations in serum levels of endogenous LH during FSH treatment in HH patients with preserved pituitary function. This is suggestive of a novel regulatory loop of LH secretion involving gonadotropin-stimulated ovarian factors whose nature and physiological relevance are yet to be disclosed, ovarian-derived kisspeptins being appealing candidates.
Similar articles
-
Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. The European Recombinant Human LH Study Group.J Clin Endocrinol Metab. 1998 May;83(5):1507-14. doi: 10.1210/jcem.83.5.4770. J Clin Endocrinol Metab. 1998. PMID: 9589647 Clinical Trial.
-
Split daily recombinant human LH dose in hypogonadotrophic hypogonadism: a nonrandomized controlled pilot study.Reprod Biomed Online. 2013 Jan;26(1):88-92. doi: 10.1016/j.rbmo.2012.09.016. Epub 2012 Oct 4. Reprod Biomed Online. 2013. PMID: 23177418 Clinical Trial.
-
Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions.J Clin Endocrinol Metab. 2000 Sep;85(9):3239-44. doi: 10.1210/jcem.85.9.6811. J Clin Endocrinol Metab. 2000. PMID: 10999815 Clinical Trial.
-
The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation.Fertil Steril. 2002 Jun;77(6):1170-7. doi: 10.1016/s0015-0282(02)03157-6. Fertil Steril. 2002. PMID: 12057724 Review.
-
Assessment of theca cell function prior to controlled ovarian stimulation: the predictive value of serum basal/stimulated steroid levels.Hum Reprod. 2010 Jan;25(1):228-34. doi: 10.1093/humrep/dep378. Epub 2009 Nov 6. Hum Reprod. 2010. PMID: 19897528 Review.
Cited by
-
Reproductive functions of Kisspeptin/KISS1R Systems in the Periphery.Reprod Biol Endocrinol. 2019 Aug 9;17(1):65. doi: 10.1186/s12958-019-0511-x. Reprod Biol Endocrinol. 2019. PMID: 31399145 Free PMC article. Review.
-
Living with Kallmann Syndrome - Analysis of Subjective Experience Reports from Women.Geburtshilfe Frauenheilkd. 2013 Nov;73(11):1112-1120. doi: 10.1055/s-0033-1350881. Geburtshilfe Frauenheilkd. 2013. PMID: 24771897 Free PMC article.
-
High-fat diet decreases the expression of Kiss1 mRNA and kisspeptin in the ovary, and increases ovulatory dysfunction in postpubertal female rats.Reprod Biol Endocrinol. 2014 Dec 26;12:127. doi: 10.1186/1477-7827-12-127. Reprod Biol Endocrinol. 2014. PMID: 25542298 Free PMC article.
-
The value of human chorionic gonadotropin stimulation test in predicting ovarian response during in-vitro fertilization.J Assist Reprod Genet. 2011 Sep;28(10):893-9. doi: 10.1007/s10815-011-9612-y. Epub 2011 Jul 21. J Assist Reprod Genet. 2011. PMID: 21779785 Free PMC article. Clinical Trial.
-
Kisspeptin/Kisspeptin Receptor System in the Ovary.Front Endocrinol (Lausanne). 2018 Jan 4;8:365. doi: 10.3389/fendo.2017.00365. eCollection 2017. Front Endocrinol (Lausanne). 2018. PMID: 29354093 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources